Health Canada advisory

Health Canada has publicly warned Canadians against injecting peptides purchased online from unauthorized sources. Vials marketed as "research use only" have been found to contain contamination and inaccurate dosing, and their use has been linked to serious harm. Read the Health Canada advisory in full.

The pitch

Scroll long enough on any fitness or biohacking corner of the internet and you'll see it: vials of BPC-157, TB-500 (thymosin beta-4), ipamorelin, CJC-1295, sermorelin, GHK-Cu, PT-141, tesamorelin, and even semaglutide sold by US-based online shops. The pitch is that these are cheap, easy to order, and — the magic phrase — "for research use only, not for human consumption."

The implication being sold is that the disclaimer creates a legal safe harbor: because the vendor said it's for research, the buyer isn't doing anything wrong. That's not how Canadian law works.

What Health Canada has actually said

Health Canada published a public advisory (April 2026) titled "Think twice before injecting peptides bought online — unauthorized products can seriously harm." The advisory (link above) warns Canadians that:

  • Peptides sold online with "research use only" labels are not authorized as drugs by Health Canada.
  • These vials have been found to contain contamination, incorrect quantities of the labeled peptide, or entirely different substances.
  • Injection of these unauthorized products has been linked to serious infections, allergic reactions, and other harm.
  • Health Canada advises Canadians to only use peptides that have been authorized as prescription drugs and to obtain them from a licensed Canadian pharmacy on a prescription from a licensed Canadian healthcare practitioner.

In Canada, the sale, importation, and advertising of unauthorized drugs is regulated by the Food and Drugs Act and its regulations. Substances sold as "research use only" for injection into humans don't get a pass — Health Canada, and the Canada Border Services Agency, can and do treat them as unauthorized drugs when they're imported. The "research use only" label is a US industry convention around lab reagents; it does not create a Canadian legal category.

The practical result: personal-use peptide vials can be seized at the border, and there's no protective regulatory framework if something goes wrong. No insurer will cover the outcome. No Canadian complaints process gets you a refund from an anonymous overseas shop.

Quality: what's actually in the vial

Even setting the law aside, the manufacturing quality of research-chemical peptides is a black box. Third-party testing has repeatedly found:

  • Peptides that don't match their labeled identity.
  • Dose quantities significantly off from what's stated.
  • Bacterial contamination inconsistent with anything you'd want to inject.
  • Endotoxin levels far above what's safe for injection.

None of this is unique to a specific vendor. It's a structural consequence of buying an "unregulated" product for an "unregulated" use.

Real risks people have run into

The specific harms Health Canada and hospital case reports have flagged include: injection-site infections requiring debridement, systemic infections, severe allergic reactions, hormonal disruption from inaccurate dosing (particularly with growth-hormone secretagogues), and reactions to contaminants that weren't listed on the label at all.

These are not hypothetical risks. They're specifically why Health Canada issued a public advisory in the first place.

Legitimate Canadian alternatives

For most of the wellness use cases people are trying to achieve with research-use-only peptides, there are honest legal alternatives:

  • For metabolic health, weight, and appetite regulation: Health Canada-authorized GLP-1s (semaglutide, tirzepatide) via a licensed Canadian telehealth clinic. See the GLP-1 guide and the provider directory.
  • For other peptide drugs with a historical Canadian authorization: verify a live DIN and marketed status in the Drug Product Database before assuming commercial access. Tesamorelin / Egrifta was associated with a narrow HIV-lipodystrophy indication, but Canadian DINs have been cancelled / sale discontinued in public records — do not treat it as an easy retail option. See the peptide guide.
  • For anti-aging and generalized wellness claims: the honest answer is that most of the specific peptide claims (BPC-157 for injury healing, TB-500 for regeneration, GHK-Cu for skin) are not supported by strong human evidence, let alone by Health Canada authorization. Sleep, strength training, and cardiovascular fitness remain the boring, evidence-based interventions.

Flatland Health only recommends Health Canada–authorized medications that licensed Canadian practitioners can prescribe through legitimate channels. Our peptide pages are educational and deliberately redirect away from gray-market vials. Always verify current DPD status — authorizations and commercial availability change.